Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011235 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Isaic Alexandru und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department X of General Surgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Lung Neoplasms, Nanomedicine, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy, Timișoara.
Abstract (Originalsprache)
Lung cancer, the leading cause of cancer-related deaths worldwide, is characterized by its aggressive nature and poor prognosis. As traditional chemotherapy has the disadvantage of non-specificity, nanomedicine offers innovative approaches for targeted therapy, particularly through the development of nanoparticles that can deliver therapeutic agents directly to cancer cells, minimizing systemic toxicity and enhancing treatment efficacy. VEGF and VEGFR are shown to be responsible for activating different signaling cascades, which will ultimately enhance tumor development, angiogenesis, and metastasis. By inhibiting VEGF and VEGFR signaling pathways, these nanotherapeutics can effectively disrupt tumor angiogenesis and proliferation. This review highlights recent advancements in nanoparticle design, including lipid-based, polymeric, and inorganic nanoparticles, and their clinical implications in improving lung cancer outcomes, exploring the role of nanomedicine in lung cancer diagnoses and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department X of General Surgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
- Department of Internal Medicine, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Department VII Internal Medicine II, Discipline of Cardiology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Department of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
- Radiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
ORCID-Profile: Lavinia Davidescu, Nadica Motofelea, Dan Costachescu, Monica Steluta Marc, Noemi Suppini, Răzvan-Lucian Coșeriu
Förderung
- Victor Babes University of Medicine and Pharmacy, Timișoara
Zitieren
APA
Alexandru, I., Davidescu, L., Motofelea, A. C., Ciocarlie, T., Motofelea, N., Costachescu, D., Marc, M. S., Suppini, N., Șovrea, A. S., Coșeriu, R. L., Bondor, D. A., Bobeică, L. G., & Crintea, A. (2024). Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011235
Vancouver
Alexandru I, Davidescu L, Motofelea AC, Ciocarlie T, Motofelea N, Costachescu D, et al. Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011235
BibTeX
@article{Alexandru2024,
author = {Alexandru, Isaic and Davidescu, Lavinia and Motofelea, Alexandru Cătălin and Ciocarlie, Tudor and Motofelea, Nadica and Costachescu, Dan and Marc, Monica Steluta and Suppini, Noemi and Șovrea, Alina Simona and Coșeriu, Răzvan-Lucian and Bondor, Daniela-Andreea and Bobeică, Laura-Gabriela and Crintea, Andreea},
title = {Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011235}
}
EUVIMED